Immunitybio Inc

IBRX

NASDAQ

Biotechnology

$7.57

USD

-0.08 (-1.05%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $8.11B

Volume 4.9M

Overview Charts Financials Peers Filings & News Analyst Ratings Technical Analysis

Peer Comparison Table

(1/4)
	KYMR	Kymera Therapeutics Inc	$9.03B	-	+134.8%	-
	PCVX	Vaxcyte Inc	$8.67B	-	-	-
	IMVT	Immunovant Inc	$8.24B	-	-	-
	RYTM	Rhythm Pharmaceuticals Inc	$7.91B	-	+53.5%	-
	IBRX	Immunitybio Inc	$7.87B	-	+192.9%	-
	TWST	Twist Bioscience Corp	$7.81B	-	+19.2%	-
	TGTX	TG Therapeutics Inc	$7.62B	17.25	+76.1%	-
	COGT	Cogent Biosciences Inc	$7.10B	-	-	-

Top Peer by Growth

Immunitybio Inc

+192.9% YoY Revenue

Lowest P/E Ratio

TG Therapeutics Inc

16.62x P/E

Best 1-Year Return

Oruka Therapeutics Inc

+605.3% Return